We are live on
!
Find out more
SPC
Slate Path Capital Portfolio holdings
AUM
$6.73B
1-Year Est. Return
95.97%
This Fund
S&P 500
This Quarter
Est. Return
+9.08%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$6.49B
AUM Growth
+$1.24B
(+24%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
12.84%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
76
New
14
Increased
15
Reduced
19
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$179M |
| 2 |
Western Digital
WDC
|
+$175M |
| 3 |
Corning
GLW
|
+$173M |
| 4 |
United Airlines
UAL
|
+$159M |
| 5 |
Ciena
CIEN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$114M |
| 2 |
Sea Limited
SE
|
+$77M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$76.2M |
| 4 |
Charter Communications
CHTR
|
+$72.8M |
| 5 |
Hewlett Packard
HPE
|
+$67.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.93% |
| 2 | Industrials | 18.96% |
| 3 | Materials | 10.83% |
| 4 | Communication Services | 9.51% |
| 5 | Consumer Discretionary | 7.99% |
Similar funds
SPS
BHM
TAM
CIMLRA
FLPIM
JCAM
MSE
CF
Slate Path Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Slate Path Capital held 76 positions worth $6.49B, up 24% from $5.25B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Slate Path Capital deployed $834M of net new capital in Q3 2024, opening 14 new positions and adding to 15 existing holdings. Its largest new stake was Walt Disney: 1,949,900 shares worth $188M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Materials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $114M trimmed.
- Slate Path Capital's largest Q3 2024 buy was Walt Disney: 1,949,900 shares worth $188M.
- Slate Path Capital added most to Western Digital in Q3 2024, an estimated $175M increase.
- Slate Path Capital's biggest Q3 2024 reduction was Teva Pharmaceuticals, cutting an estimated $114M.
- Slate Path Capital fully exited Barrick Mining in Q3 2024, selling an estimated $54.6M.
- Slate Path Capital's ten largest holdings make up 41% of its $6.49B portfolio in Q3 2024.
- Slate Path Capital opened 14 new positions and closed 8 in Q3 2024.
- Slate Path Capital's portfolio value rose 24% quarter-over-quarter to $6.49B.
Based on Slate Path Capital's 13F filing for Q3 2024, filed 14 Nov 2024.